rs137976282

Variant summary

Our verdict is Likely benign. The variant received -6 ACMG points: 0P and 6B. BP4_ModerateBS1

The NM_032444.4(SLX4):​c.421G>T​(p.Gly141Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00081 in 1,614,190 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G141V) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00069 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00082 ( 1 hom. )

Consequence

SLX4
NM_032444.4 missense

Scores

1
3
14

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:10B:4

Conservation

PhyloP100: 0.878

Publications

16 publications found
Variant links:
Genes affected
SLX4 (HGNC:23845): (SLX4 structure-specific endonuclease subunit) This gene encodes a protein that functions as an assembly component of multiple structure-specific endonucleases. These endonuclease complexes are required for repair of specific types of DNA lesions and critical for cellular responses to replication fork failure. Mutations in this gene were found in patients with Fanconi anemia. [provided by RefSeq, Sep 2016]
SLX4 Gene-Disease associations (from GenCC):
  • Fanconi anemia complementation group P
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • Fanconi anemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary breast carcinoma
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • familial ovarian cancer
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -6 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.21543238).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000689 (105/152298) while in subpopulation NFE AF = 0.00104 (71/68034). AF 95% confidence interval is 0.000848. There are 0 homozygotes in GnomAd4. There are 54 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_032444.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLX4
NM_032444.4
MANE Select
c.421G>Tp.Gly141Trp
missense
Exon 2 of 15NP_115820.2Q8IY92-1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SLX4
ENST00000294008.4
TSL:5 MANE Select
c.421G>Tp.Gly141Trp
missense
Exon 2 of 15ENSP00000294008.3Q8IY92-1
SLX4
ENST00000466154.5
TSL:1
n.716G>T
non_coding_transcript_exon
Exon 1 of 7
SLX4
ENST00000486524.1
TSL:2
n.1049G>T
non_coding_transcript_exon
Exon 2 of 4

Frequencies

GnomAD3 genomes
AF:
0.000690
AC:
105
AN:
152180
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000720
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00104
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.000819
AC:
206
AN:
251488
AF XY:
0.000912
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.00107
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000231
Gnomad NFE exome
AF:
0.00117
Gnomad OTH exome
AF:
0.000652
GnomAD4 exome
AF:
0.000822
AC:
1202
AN:
1461892
Hom.:
1
Cov.:
31
AF XY:
0.000829
AC XY:
603
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.0000597
AC:
2
AN:
33480
American (AMR)
AF:
0.00105
AC:
47
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00130
AC:
34
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000243
AC:
21
AN:
86258
European-Finnish (FIN)
AF:
0.000225
AC:
12
AN:
53418
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5768
European-Non Finnish (NFE)
AF:
0.000928
AC:
1032
AN:
1112012
Other (OTH)
AF:
0.000795
AC:
48
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
83
165
248
330
413
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000689
AC:
105
AN:
152298
Hom.:
0
Cov.:
33
AF XY:
0.000725
AC XY:
54
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41562
American (AMR)
AF:
0.000719
AC:
11
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.000414
AC:
2
AN:
4830
European-Finnish (FIN)
AF:
0.000471
AC:
5
AN:
10610
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00104
AC:
71
AN:
68034
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
5
10
15
20
25
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000838
Hom.:
0
Bravo
AF:
0.000604
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.000519
AC:
2
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00105
AC:
9
ExAC
AF:
0.000824
AC:
100
EpiCase
AF:
0.000927
EpiControl
AF:
0.00207

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
3
1
Fanconi anemia complementation group P (4)
-
2
1
not provided (3)
-
1
1
Fanconi anemia (2)
-
1
1
not specified (2)
-
1
-
Fanconi anemia complementation group A (1)
-
1
-
Hereditary breast ovarian cancer syndrome (1)
-
1
-
Malignant tumor of breast (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.28
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
18
DANN
Uncertain
0.98
DEOGEN2
Benign
0.14
T
Eigen
Benign
-0.33
Eigen_PC
Benign
-0.48
FATHMM_MKL
Benign
0.19
N
LIST_S2
Benign
0.54
T
M_CAP
Pathogenic
0.64
D
MetaRNN
Benign
0.22
T
MetaSVM
Benign
-0.81
T
MutationAssessor
Benign
1.7
L
PhyloP100
0.88
PrimateAI
Benign
0.24
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.073
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0040
D
Polyphen
0.96
D
Vest4
0.80
MVP
0.30
MPC
0.36
ClinPred
0.031
T
GERP RS
2.5
Varity_R
0.099
gMVP
0.19
Mutation Taster
=92/8
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs137976282; hg19: chr16-3658545; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.